Advertisement

Coronavirus Myths for People With Arthritis

Separating fact from fiction: Essential truths about COVID-19 risks, vaccines, and arthritis management to protect your health.

By Medha deb
Created on

People with arthritis, particularly those with inflammatory or autoimmune types like rheumatoid arthritis, have faced unique concerns during the COVID-19 pandemic. Misinformation has spread rapidly, creating unnecessary fear about infection risks, medications, vaccines, and recovery. This article debunks prevalent myths using evidence from authoritative sources like the Arthritis Foundation, CDC, and rheumatology studies, empowering you with accurate information to manage your health confidently.

Myth 1: People with Arthritis Are at Much Higher Risk of Severe COVID-19

While individuals with autoimmune conditions worry about heightened vulnerability, studies indicate that people with inflammatory arthritis are not inherently more likely to experience severe COVID-19 complications solely due to their arthritis diagnosis. Factors like obesity, diabetes, or uncontrolled disease activity elevate risks more significantly than arthritis alone. For instance, the COVID-19 Global Rheumatology Alliance registry data shows no disproportionate complication rates among rheumatology patients compared to the general population when controlling for comorbidities.

Protective strategies remain crucial: maintain vaccinations, monitor disease activity, and adopt lifestyle measures like regular exercise and anti-inflammatory diets to mitigate overall risks. High disease activity, not the arthritis itself, correlates with poorer outcomes, underscoring the importance of consistent treatment adherence.

Myth 2: Arthritis Medications Increase COVID-19 Infection Risk Dramatically

A common fear is that immunosuppressive drugs like methotrexate, biologics (e.g., TNF inhibitors), or JAK inhibitors make arthritis patients highly susceptible to infections. Evidence refutes this exaggeration; while mild immunosuppression may slightly elevate infection odds, these medications do not dramatically heighten severe COVID-19 risk.

  • Early pandemic data from the Global Rheumatology Alliance found no increased hospitalization or mortality linked to common DMARDs or biologics.
  • Recent studies confirm vaccinated patients on these therapies mount adequate immune responses, with boosters further enhancing protection.
  • Do not stop medications without consulting your rheumatologist, as uncontrolled arthritis worsens overall health and vulnerability.

During shortages or concerns, discuss alternatives with your doctor, but continuity is key for joint protection and immune balance.

Myth 3: COVID-19 Vaccines Are Ineffective or Dangerous for Arthritis Patients

Vaccine hesitancy stems from myths that immunosuppressed individuals won’t benefit or face higher side effects. In reality, COVID-19 vaccines are safe and effective for people with arthritis, though responses may be slightly attenuated in those on high-dose immunosuppressants.

MythFactEvidence
Vaccines don’t work on immunosuppressed patientsThey provide substantial protection; boosters restore robust immunityArthritis Foundation and CDC data
Vaccines trigger arthritis flaresRare; benefits outweigh minimal risksGlobal Rheumatology Alliance
Skip boosters if previously infectedHybrid immunity (infection + vaccine) is strongestCDC guidelines

Stay current with boosters, especially during surges, and monitor for symptoms post-vaccination.

Myth 4: Once You’ve Had COVID-19, You’re Immune and Don’t Need Precautions

Reinfection is possible, and prior infection does not confer lifelong immunity. Vaccinated or previously infected individuals can still contract COVID-19, potentially with long COVID risks. Experts recommend layering protections: updated vaccines, masking in high-risk settings, and hand hygiene regardless of prior exposure.

For arthritis patients, reinfection risks mirror the general population but emphasize avoiding unnecessary exposures to preserve health.

Myth 5: Children with Juvenile Arthritis Face Extreme COVID-19 Risks

Parents fear disproportionate dangers for kids with juvenile idiopathic arthritis (JIA). Data shows children with JIA have infection risks similar to healthy peers, with rare severe cases unless comorbidities exist. Symptoms in children are often milder: fever, cough, fatigue, without heightened multisystem inflammatory syndrome risks tied to JIA treatments.

  • Vaccinate the entire family to protect vulnerable children.
  • Maintain medications; no evidence supports pausing for COVID-19.
  • Monitor for symptoms and isolate promptly if exposed.

Myth 6: COVID-19 Recovery Is Worse for Arthritis Patients

Concerns about prolonged hospitalization or higher mortality persist. Rheumatology registry data reveals arthritis patients recover comparably to others, with autoimmune diseases not independently raising mortality. Hospital outcomes are favorable, especially for those on standard therapies.

Post-recovery, monitor for long COVID symptoms like fatigue, which may overlap with arthritis flares, and resume treatments promptly.

Myth 7: Masks Are No Longer Needed Regardless of Personal Risk

CDC guidance evolves, but for immunosuppressed arthritis patients, experts advise personalized masking in crowded indoor spaces during high community transmission. Dr. William Hayes Wilson, rheumatology chief at Piedmont Hospital, emphasizes consulting doctors before forgoing masks.

Additional Myths and Facts

  • Myth: Supplements like vitamin D or zinc prevent COVID-19 in arthritis patients. Fact: They support immunity but are not substitutes for vaccines or precautions.
  • Myth: Arthritis diet cures COVID-19 vulnerability. Fact: Anti-inflammatory diets aid overall health but don’t eliminate viral risks.
  • Myth: Experimental COVID-19 treatments interfere with arthritis care. Fact: Most are compatible; coordinate with specialists.

Frequently Asked Questions (FAQs)

Q: Am I more likely to have complications from COVID-19 if I have inflammatory arthritis?

A: Studies show no increased complications from arthritis alone; manage comorbidities and disease activity to minimize risks.

Q: Can I get reinfected with COVID-19 after vaccination or prior infection?

A: Yes, but vaccines and boosters significantly reduce severe outcomes. Layer protections to avoid reinfection.

Q: Should I stop my arthritis medications during a COVID-19 outbreak?

A: No, unless advised by your doctor. Stopping can worsen arthritis and overall health.

Q: Are COVID-19 vaccines recommended for children with juvenile arthritis?

A: Yes, following CDC schedules; they are safe and protective for JIA patients.

Q: Does high COVID-19 community spread affect my masking decisions?

A: Yes, mask indoors in crowded areas if at higher risk, per expert guidance.

Protective Measures for Arthritis Patients

Beyond debunking myths, prioritize:

  • Stay up-to-date on COVID-19 vaccines and boosters.
  • Practice hand hygiene and distancing during surges.
  • Maintain arthritis treatment plans.
  • Adopt healthy lifestyles: exercise, sleep, balanced diet.
  • Join registries like the Global Rheumatology Alliance to contribute data.

Consult rheumatologists for tailored advice, as guidelines evolve with new variants.

References

  1. Coronavirus and Arthritis: What You Need to Know — Arthritis Foundation. 2023-01-03. https://www.arthritis.org/about-us/news-and-updates/coronavirus-and-arthritis-what-you-need-to-know
  2. COVID-19 FAQs: Infection Risk and Prevention — Arthritis Foundation. 2023-01-03. https://www.arthritis.org/health-wellness/about-arthritis/related-conditions/other-diseases/covid-19-faqs-infection-risk-and-prevention
  3. Debunking Arthritis Myths — Arthritis Foundation. Accessed 2026. https://www.arthritis.org/health-wellness/about-arthritis/understanding-arthritis/debunking-arthritis-myths
  4. Fact Check Your Fork – Arthritis Diet Myths — Arthritis Foundation. Accessed 2026. https://www.arthritis.org/liveyes/podcast/episodes/arthritis-diet-myths-142
  5. COVID-19 Vaccination Basics — Centers for Disease Control and Prevention (CDC). 2025-12-01. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html
Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb